Accidental Double Dose of Allegra 180 mg: Clinical Effects
Taking 360 mg of fexofenadine (two 180 mg Allegra tablets) accidentally is generally safe and unlikely to cause significant adverse effects, though it exceeds the recommended daily dose.
What to Expect
The FDA labeling explicitly states not to take more than one 180 mg tablet in 24 hours 1. However, clinical research provides reassuring data about overdose scenarios:
Safety Profile at Double Dose
High-dose fexofenadine (360 mg) has been extensively studied and shows no significant adverse effects:
No CNS impairment: A controlled study specifically evaluated 360 mg fexofenadine and found it indistinguishable from placebo in all cognitive and psychomotor tests, including critical flicker fusion, choice reaction time, compensatory tracking, and subjective sedation assessments 2
No sedation: Unlike first-generation antihistamines, fexofenadine does not cross the blood-brain barrier even at supraclinical doses 2, 3
Possible mild stimulation: Some studies have shown that 360 mg may actually produce mild stimulating effects and improved performance on cognitive tasks, though this is not clinically concerning 4
Expected Clinical Course
Most likely scenario: No symptoms or minimal effects
- The person will likely experience no noticeable difference from their usual dose
- Fexofenadine is classified as a second-generation antihistamine with minimal side effects even at double the therapeutic dose 5
- The drug has a half-life of approximately 14.4-14.6 hours, so the excess will be eliminated naturally 5
Management Recommendations
No specific intervention is typically needed:
- Monitor for any unusual symptoms (though unlikely)
- Ensure adequate hydration
- Resume normal dosing schedule the following day (do not skip the next dose to "compensate")
- Contact a healthcare provider if any concerning symptoms develop
Important Caveats
Special populations requiring medical consultation:
- Kidney disease patients: Should contact their doctor, as the FDA label specifically recommends asking a doctor before use in this population 1
- Adults ≥65 years: Should also consult their physician per FDA guidance 1
Why This Differs from Other Antihistamines
Fexofenadine's safety profile at higher doses distinguishes it from first-generation antihistamines, which cause dose-dependent CNS depression, anticholinergic effects, and performance impairment even at therapeutic doses 5. The lack of brain penetration makes accidental overdose far less concerning than with older antihistamines like diphenhydramine or promethazine.